Raleigh firm's drug could help fight rare Covid-related syndrome in children
As Covid-19 cases rise among children, a celiac treatment developed in Raleigh may hold answers to treating a rare, potentially deadly syndrome linked to the disease.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Lauren Ohnesorge Source Type: news
More News: Biotechnology | Celiac Disease | Children | Coeliac Disease | COVID-19 | Health Management